0001209191-16-091523.txt : 20160114
0001209191-16-091523.hdr.sgml : 20160114
20160114190633
ACCESSION NUMBER: 0001209191-16-091523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160112
FILED AS OF DATE: 20160114
DATE AS OF CHANGE: 20160114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tobira Therapeutics, Inc.
CENTRAL INDEX KEY: 0001311596
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030422069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-741-6625
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Tibira Therapeutics, Inc.
DATE OF NAME CHANGE: 20150506
FORMER COMPANY:
FORMER CONFORMED NAME: Regado Biosciences Inc
DATE OF NAME CHANGE: 20041215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Jeffrey H
CENTRAL INDEX KEY: 0001301173
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35953
FILM NUMBER: 161343846
MAIL ADDRESS:
STREET 1: BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-12
0
0001311596
Tobira Therapeutics, Inc.
TBRA
0001301173
Cooper Jeffrey H
C/O TOBIRA THERAPEUTICS, INC.
701 GATEWAY BOULEVARD STE. 300
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Options (right to buy)
7.91
2016-01-12
4
A
0
17778
0.00
A
2026-01-11
Common Stock
17778
17778
D
The shares will vest ratably over 12 months of continuous service beginning on January 1, 2016, subject to the terms of the Issuer's 2013 Equity Compensation Plan.
/s/ Brian Savage, attorney-in-fact
2016-01-14